Associated Papers
Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial.
Tchekmedyian V et al.
Thyroid : Official Journal of the American Thyroid Association, 2022
Select a paper to view details